ClearPoint Neuro WKN: A2PZ3E ISIN: US18507C1036 Kürzel: CLPT Forum: Aktien Thema: Hauptdiskussion

Danke dir 👍

Nettes write up imo 😎 https://maxwellhouse99.substack.com/p/2-clearpoint-neuro-insane-in-the?r=cu51m&utm_campaign=post&utm_medium=web&utm_source=twitter

ClearPoint Neuro Set to Join Russell 3000® Index https://www.globenewswire.com/news-release/2021/06/14/2246614/0/en/ClearPoint-Neuro-Set-to-Join-Russell-3000-Index.html ...is set to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.   ....

💎👍🏻

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease https://www.globenewswire.com/news-release/2021/06/08/2243505/25687/en/ClearPoint-Neuro-Inc-Congratulates-BlueRock-Therapeutics-on-First-Patient-Dosed-with-DA01-in-Phase-1-Study-in-Patients-with-Advanced-Parkinson-s-Disease.html First Ever Stem Cell Clinical Trial Patient Treated Using Entire ClearPoint Platform

ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software https://www.globenewswire.com/news-release/2021/05/18/2232002/0/en/ClearPoint-Neuro-Inc-Announces-First-in-Human-Cases-of-the-SmartFrame-Array-Neuro-Navigation-System-and-Software.html

https://www.fool.com/earnings/call-transcripts/2021/05/12/clearpoint-neuro-inc-clpt-q1-2021-earnings-call-tr/

👍

ClearPoint Neuro EPS beats by $0.01, beats on revenue https://seekingalpha.com/news/3694800-clearpoint-neuro-eps-beats-0_01-beats-on-revenue • ClearPoint Neuro (NASDAQ:CLPT): Q1 GAAP EPS of -$0.13 beats by $0.01. • Revenue of $4.03M (+29.2% Y/Y) beats by $0.76M.

ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’ https://www.globenewswire.com/news-release/2021/05/11/2227629/25687/en/ClearPoint-Neuro-Reports-Record-Revenue-in-First-Quarter-2021-Results-Announces-FDA-Clearance-of-the-SmartFrame-Array.html

ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room https://www.globenewswire.com/news-release/2021/05/10/2226744/0/en/ClearPoint-Neuro-Announces-Partnership-With-D-K-Engineering-for-Development-of-Robotic-System-for-the-MRI-Suite-and-Operating-Room.html

dabei

ClearPoint Neuro: A Biotech Portfolio Play https://seekingalpha.com/article/4417555-clearpoint-neuro-biotech-portfolio-play Summary • Potential for 100 gene therapy trials to be using ClearPoint. • Expect significant growth in 2H 2021 as elective surgeries rebound and clinical trials restart. • Recent expansion to Europe augurs well for European biologics partners. • We see potential for $100M+ revenues and 30%+ net margins by 2025. ...

https://www.marketwatch.com/press-release/10-k-clearpoint-neuro-inc-2021-03-22

🍀

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results https://www.globenewswire.com/news-release/2021/03/04/2187587/0/en/ClearPoint-Neuro-Reports-Fourth-Quarter-and-Full-Year-2020-Results.html Company Reports Record Revenues 2020 Full Year and Fourth Quarter Highlights • Reported fourth quarter 2020 revenue of $3.7 million, an increase of 16% compared with the fourth quarter of 2019. Reported revenue of $12.8 million for 2020, a 14% increase over 2019 and representing the sixth consecutive year of growth. • Increased biologics and drug delivery revenue to $5.0 million in 2020, a 109% increase over 2019, driven by service revenue. • Supported 682 cases in 2020 despite the continued challenges posed by the COVID-19 pandemic. • Completed a convertible note financing facility under which notes aggregating $25.0 million were issued, and ended 2020 with cash and cash equivalents totaling $20.1 million. ....